MODL-05. DISCOVERY OF DYNAMIC MINIMAL RESIDUAL DISEASE STATES IN ADULT GLIOBLASTOMA USING SINGLE CELL TECHNOLOGY. (14th November 2022)

• Record Type: Journal Article
• Authors: Zador, Zsolt; Mikolajewicz, Nicholas; Han, Hong; Voisin, Mathew; Venugopal, Chitra; Chokshi, Chirayu; Maich, Will; Jason, Moffat; Zadeh, Gelareh; Singh, Sheila
• Is Part Of: Neuro-oncology. Volume 24(2022)Supplement 7
• Page Start: vii291
• Page End: vii292
• Publication Date: 2022-11-14
• Subjects: Brain Neoplasms -- Periodicals; Brain -- Tumors -- Periodicals; Brain -- Cancer -- Periodicals; Nervous system -- Cancer -- Periodicals; 616.99481
• DOI: 10.1093/neuonc/noac209.1133
• Languages: English
• ISSNs: 1522-8517

Abstract

Abstract: Persister states are proposed oncogenic substrates of disease recurrence in cancer. Recent concepts suggest persisters may occur in dynamic states of the cell cycle (such as cycling and non-cycling states). We therefore investigated biological programs at the post-treatment minimal residual disease (MRD) state following standard chemoradiotherapy in patient-derived xenograft models of GBM. Our analysis of single cell RNA sequencing (scRNA-seq) data from 2704 tumor cells (929 cells post treatment, 1775 matched controls) yielded a cellular profile for non-cycling and cycling persister states. We validated these programs in 3 independent scRNA-seq datasets of human glioblastoma specimens consisting of over 16, 000 cells from various genetic backgrounds, including an internal two patient-matched primary and recurrent GBM pairs with over 13, 000 cells. Finally, we determined that clones identified based on large scale chromosomal rearrangements converge on previously identified persister states including the dynamic states discovered in our study. Our results provide new evidence towards dynamic persister states in glioblastoma, further analysis of these dynamic states is critical to targeting this incurable disease.